BioScrip's Turnaround Story Will Turn Around Some Heads
Douglas E. Johnston - at Seeking Alpha - Thu Feb 12, 7:56AM CST
BIOS: 6.04 (-0.06), HSP: 87.35 (unch)
BioScrip Nominates Three New Independent Directors
PR Newswire - Mon Feb 09, 7:00AM CST
BioScrip, Inc. (NASDAQ: BIOS) (the "Company"
BIOS: 6.04 (-0.06)
BioScrip CFO bids adieu
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 3:44PM CST
BIOS: 6.04 (-0.06)
BioScrip Announces Resignation of Hai V. Tran as Chief Financial Officer
PR Newswire - Wed Feb 04, 3:01PM CST
BioScrip, Inc. (NASDAQ: BIOS) (the "Company"
BIOS: 6.04 (-0.06)
Community Bank Shares of Indiana, Inc. Names New Board Member
Business Wire - Wed Feb 04, 7:01AM CST
Community Bank Shares of Indiana, Inc. (NASDAQ: CBIN), the holding company for Your Community Bank and The Scott County State Bank, today has named Phillip J. Keller as a member of its Board of Directors.
PMC: 24.40 (-0.18), BIOS: 6.04 (-0.06), CBIN: 27.23 (+0.08)
The Shuman Law Firm Investigates BioScrip, Inc.
Business Wire - Tue Jan 27, 7:00PM CST
The Shuman Law Firm announces that it is investigating potential claims against certain officers and directors of BioScrip, Inc. ("BioScrip" or the "Company"
BIOS: 6.04 (-0.06), NVS: 102.20 (-0.17)
Robbins Arroyo LLP Is Investigating the Officers and Directors of BioScrip, Inc. (BIOS) on Behalf of Shareholders
PR Newswire - Thu Jan 22, 1:07PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of BioScrip, Inc. (NASDAQGS: BIOS) breached their fiduciary duties to shareholders. BioScrip is a pharmacy benefit management and specialty pharmaceutical company that partners with healthcare providers to manage prescription drug costs in addition to providing pharmacy benefit products and mail order pharmacy services.
BIOS: 6.04 (-0.06)
OTC Daily Alert Stock Watch - BioScrip BioScrip, Inc. (Nasdaq: BIOS)
WorldStockWire - Mon Dec 29, 5:30PM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
BIOS: 6.04 (-0.06)
Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
CVO: 1.92 (-0.04), CKSW: 8.08 (-0.01), AVHI: 15.16 (+0.04), BIOS: 6.04 (-0.06), CKEC: 29.96 (+0.89)
United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), LHCG: 30.42 (-0.57), BIOS: 6.04 (-0.06), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
BioScrip Supports the Toys for Tots Fund Drive and Collection for Second Year
PR Newswire - Wed Dec 10, 5:35PM CST
BioScrip, Inc. (NASDAQ: BIOS) today announced that it is supporting the Toys for Tots fundraising and toy drive for the second year. The BioScrip family of companies treats thousands of patients across the country every day, providing intravenous therapies in alternate settings that help many avoid hospitalization or readmission. Since many BioScrip infusion patients are children, supporting the Toys for Tots program has been the perfect holiday giving project. Last year BioScrip contributed $25,000 to the Toys for Tots national campaign, in addition to collecting hundreds of toys for children in need. In its second year as a National Corporate Partner, BioScrip will make a donation for every patient started on service during the holiday season and has pledged a total possible contribution of $50,000 to Toys for Tots.
BIOS: 6.04 (-0.06)
BioScrip to Present at Bank of America Merrill Lynch 2014 Leveraged Finance Conference
PR Newswire - Wed Nov 26, 7:00AM CST
BioScrip®, Inc. (NASDAQ: BIOS) announced today that Richard M. Smith, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference as follows:
BIOS: 6.04 (-0.06)
Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 24, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
BUD: 121.72 (-0.80), AIRM: 45.33 (+0.24), CKSW: 8.08 (-0.01), BONT: 5.79 (+0.04), BIOS: 6.04 (-0.06)
Biotech Weekly: Here Come The Institutional Holdings Updates
Daniel Ward - at Seeking Alpha - Mon Nov 17, 7:31AM CST
LOXO: 11.91 (-0.24), TRGT: 2.50 (-0.01), BOTA: 2.60 (-0.06), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), BIOS: 6.04 (-0.06), RGDO: 1.17 (+0.02), EXEL: 2.48 (+0.20), AMPH: 12.76 (+0.02)
Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday
XLS: 24.15 (+0.04), CPF: 23.66 (+0.02), BRS: 61.71 (+3.65), BIOS: 6.04 (-0.06), AVG: 20.73 (+0.25)
BioScrip (BIOS) Q3 Loss Wider than Expected, Revenues Top - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:10PM CST
BioScrip, Inc. (BIOS) recently declared its third-quarter 2014 results.
BSX: 14.98 (+0.24), ICUI: 88.98 (+0.42), ABAX: 60.93 (+0.65), BIOS: 6.04 (-0.06)
BioScrip's (BIOS) CEO Richard Smith on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:30PM CST
BIOS: 6.04 (-0.06)